Spotlight
Areas of Expertise (10)
Business
Healthcare Economics and Policy
Pharmaceutical Industries
Applications in Healthcare
Operations Management
Business Analytics
Supply Chain Management
Analytics Applications
Healthcare Industry
Drug pricing
Biography
Professor Iacocca is adept at explaining the complexities of the U.S. healthcare economy and pharmaceutical drug pricing system in a way that provides clarity and understanding for her audience. Her research is focused primarily on the healthcare industry, with specific focus on supply chains and optimization. She also more generally completes research in operations and analytics.
Education (3)
Rutgers University: PhD
The University of Scranton: MBA
The University of Scranton: BS
Select Accomplishments (5)
Emerald Literati Network Award for Excellence (professional)
2016 Selected by the editors of the International Journal of Quality & Reliability Management for the paper “Improving the Quality of Environmental Management: Impact on Shareholder Value”
Awarded 2nd Place in the INFORMS Annual Case Competition (professional)
2015 Presented case at the INFORMS Annual Meeting in Philadelphia, PA.
Emerald Literati Network Award for Excellence
2014 Selected by the editors of the International Journal of Pharmaceutical and Healthcare Marketing for the paper “Resell versus direct models in brand drug distribution”
Highly Commendable Paper Award (professional)
2013 Selected by the editors of the International Journal of Pharmaceutical and Healthcare Marketing for the paper “Resell versus direct models in brand drug distribution”
Recipient of the “KSOM Professor of the Year” Award (professional)
2013 Determined by student vote
Links (1)
Affiliations (4)
- Data Analytics, Statistics, and Operations Consultant, Fortune 50 Company
- Member, Institute for Operations Research and Management Science (INFORMS)
- Member, Decision Sciences Institute (DSI)
- Member, The Association for Operations Management (APICS)
Select Media Appearances (3)
Baltimore Bridge Collapse Raises Questions About Safety Around Philly-Area Bridges
6 ABC
2024-03-27
While Philadelphia may not be as vulnerable to a bridge collapse, its waterways will still feel the impacts from Baltimore. "Consumers are perhaps going to see that there's a delay in products," shared Villanova University's Kathleen Iacocca.
GUEST VIEW: The healthcare industry is sick: But can it afford to get better?
American Pharmacy News online
2017-06-30
Right now, President Trump and lawmakers in Washington are wrangling over the details of a proposed healthcare law that would “repeal and replace” Obamacare. Through all of the rhetoric and political jockeying, it’s important to remember that there is a huge industry in the middle of this fight. And that industry is in crisis.
Pharma seeks growth in eyecare
Pharmaceutical Commerce
2016-11-07
But where some see this as a cautionary tale, others see a potentially successful new idea poorly executed. “It’s a shame to think of this as a failure, because I do think a model like this could work,” says Kathleen Iacocca, PhD, an assistant professor at Villanova University School of Business, who has studied drug supply chains. “The issue was the insured. The company took a leap of faith without checking to make sure if insurance would actually pay. But imagine if a manufacturer could partner with a third party where pre-authorization could take place. That model would be groundbreaking.”
Select Academic Articles (5)
Why brand drugs priced higher than generic equivalents
International Journal of Pharmaceutical and Healthcare MarketingKathleen Iacocca, James Sawhill, Yao Zhao
2015
The point of purchase decision in a supply chain with value-added reselling
International Journal of Production ResearchKingsley Gnanendran and Kathleen Iacocca
2015
Resell vs. Direct Models: US Branded Drug Distribution in the Future
Pharmaceutical ExecutiveIacocca, K., Zhao, Y.
2015
Resell versus direct models in brand drug distribution
International Journal of Pharmaceutical and Healthcare MarketingKathleen Iacocca, Yao Zhao, Adam Fein
2013
A multiple regression model to explain the cost of brand-drugs
Socio-Economic Planning SciencesKathleen Iacoccaa, JamesSawhill, YaoZhao
2012
Social